Optimal therapy for IgG4 disease and how it may change. — ASN Events

Optimal therapy for IgG4 disease and how it may change. — ASN Events

Optimal therapy for IgG4 disease and how it may change.

Optimal therapy for IgG4 disease and how it may change. (112512)

Karuna Keat ¹

Immunology Unit, Dept. of Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia

To be advised

Authors contributing to this presentation.

Keat, K

Clinical Immunologist and Allergist at Campbelltown Public hospital Hospital , and has special interests and expertise in management in IgG4 related disease, vasculitis and interstitial lung disease. Part of the working group in the classification criteria for IgG4 related disease. Campbelltown was a site for the Mitigate trial in IgG4 related disease.